Federal efforts to inspect a baby formula factory linked to the nationwide shortage were delayed by COVID-19, scheduling conflicts and even a missing piece of mail, according to prepared testimony from the head of the FDA.
The first batch of imported baby formula under "Operation Fly Formula" arrived in the United States on Sunday as the Biden administration tries to alleviate the nationwide baby formula shortage.
Califf will tell lawmakers that the FDA began planning to visit the Sturgis, Michigan, plant in early December, with inspectors set to arrive on Dec. 30. But Abbott said that about a dozen of its employees had recently tested positive for COVID-19 and requested a delay. As a result, the FDA didn't begin its inspection until Jan. 31.
"Because it was a negotiation process with a regulated firm, the U.S. government did not completely control the timeline," states Califf's written testimony.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA chief: COVID, mail mix-up delayed action on baby formulaThe head of the Food and Drug Administration is testifying about a series of setbacks that led to a months-long delay in inspecting the plant at the center of a nationwide baby formula shortage
Read more »
Opinion | Why Is the FDA Seizing Baby Formula During a Baby Formula Shortage?From WSJopinion: The FDA’s actions have exacerbated the baby formula shortage problem they were trying to solve, write scottlincicome and emilyekins
Read more »
Colorado Congresswoman Diana DeGette To Grill Baby Formula Manufacturers, FDA Over ShortageColorado Congresswoman Diana DeGette is leading a federal inquiry into the nation's baby formula shortage. DeGette is the Chair of the House Energy and Commerce Committee's Oversight and Investigations Subcommittee. She is also a new grandmother who understands the sense of panic and urgency gripping parents.
Read more »
U.S. FDA declines to authorize Verrica's viral skin disease treatmentThe U.S. Food and Drug Administration (FDA) declined to approve Verrica Pharmaceuticals Inc's drug for the treatment of a viral skin disease known as molluscum contagiosum, the company said on Tuesday.
Read more »
FDA Chief to Detail Why Inspection of Baby Formula Plant Was DelayedThe head of the Food and Drug Administration is preparing to tell lawmakers about events that led to a months-long gap before inspecting the plant at the center of a nationwide baby formula shortage.
Read more »